Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Busy address KBO
15 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
ELINE LAMBERT PHARMACONSULT & INVESTMENTS from Antwerpen, company number BE1021669524, closed financial year 2025 with a result of € 28,951 after tax. For that financial year ELINE LAMBERT PHARMACONSULT & INVESTMENTS recorded a gross margin of € 37,811 and equity of € 33,951. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 4, 2026.
€ 33,951
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 28,951
Profit after tax over the fiscal year.
€ 34,810
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 28,951.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 398
Supplier invoices still open on the last day of the fiscal year.
€ 13,210
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
What happened to ELINE LAMBERT PHARMACONSULT & INVESTMENTS?
What happened at ELINE LAMBERT PHARMACONSULT & INVESTMENTS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 28,951. filed late Source: NBB ↗
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- New establishment in Antwerpen. KBO
- Eline Lambert became a director. NBB
In short
Paid € 7,689 in corporate taxes since 2025.
Management
Behind ELINE LAMBERT PHARMACONSULT & INVESTMENTS is Eline Lambert.
Directors
According to the 2025 annual accounts
Eline Lambert
Director
since 2025
Establishments
Establishment units
Physical locations of this company
Léon Stynenstraat 70 box 1904
2000 Antwerpen
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 15 companies are registered at this address.
All companies at this address →MANAGEMENT DECISIONS CONSULTING SERVICES INTERNATIONAL
€ -2,924 gross margin · 2025
F2 - MANAGEMENT
€ 147,960 gross margin · 2025
Dr. Venetia ANDREAKOU
€ 185,384 gross margin · 2025
RAYAN GH
€ 257,938 revenue · 2025
KHAZA GROUP
€ 15,318 gross margin · 2025
+10 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- Eline Jeanine Henri LAMBERT(oprichter) 100%
Details
- Company number
- 1021.669.524
- VAT number
- BE 1021.669.524
- Registered office
- Léon Stynenstraat 70 bus 1904, 2000 Antwerpen
- Names & denominations
- ELINE LAMBERT PHARMACONSULT & INVESTMENTS
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 31 March 2025
- Peppol
- Active · Active since 27 Nov 2025
- Activities · NACE
Overige zakelijke dienstverlening, neg
Bemiddelingsactiviteiten voor de gespecialiseerde detailhandel